CompletedPhase 2NCT01303952

Therapy of Chronic Cold Agglutinin Disease With Eculizumab

Studying Cold agglutinin disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Essen
Principal Investigator
Alexander Roeth, MD
Department of Hematology, University Hospital Essen
Intervention
Eculizumab(drug)
Enrollment
13 enrolled
Eligibility
18 years · All sexes
Timeline
2011 – 2015

Study locations (1)

Collaborators

Alexion Pharmaceuticals, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01303952 on ClinicalTrials.gov

Other trials for Cold agglutinin disease

Additional recruiting or active studies for the same condition.

See all trials for Cold agglutinin disease →

← Back to all trials